The quarter revealed catastrophic operational metrics: operating margins excluding other income collapsed to -243.37%, whilst net profit margins deteriorated to -121.69%. With revenues stagnating at ₹0.83 crores despite a modest 12.16% sequential uptick, the company's core business model appears fundamentally broken, raising serious questions about viability and the path to profitability.
The Mumbai-headquartered firm, incorporated in June 1982 and historically engaged in pharmaceutical manufacturing and trading, has undergone multiple business diversifications over the decades—including a brief foray into toy manufacturing—yet none have yielded sustainable profitability. The company's current operational profile remains opaque, with revenues barely registering above ₹2-3 crores annually and persistent losses eroding shareholder value systematically.
| Quarter | Net Sales (₹ Cr) | QoQ Growth | YoY Growth | Net Profit (₹ Cr) | PAT Margin |
|---|---|---|---|---|---|
| Mar'26 | 0.83 | +12.16% | +9.21% | -1.01 | -121.69% |
| Dec'25 | 0.74 | +10.45% | -1.33% | -0.67 | -90.54% |
| Sep'25 | 0.67 | -10.67% | -2.90% | -0.28 | -41.79% |
| Jun'25 | 0.75 | -1.32% | — | -0.25 | -33.33% |
| Mar'25 | 0.76 | +1.33% | — | -0.37 | -48.68% |
| Dec'24 | 0.75 | +8.70% | — | -0.22 | -29.33% |
| Sep'24 | 0.69 | — | — | -0.16 | -23.19% |
Financial Performance: A Harrowing Descent into Operating Losses
The Q4 FY26 results paint a picture of a company in severe financial distress. Net sales inched up to ₹0.83 crores from ₹0.74 crores in Q3 FY26, representing a 12.16% quarter-on-quarter improvement, yet this modest top-line growth proved wholly insufficient to stem the haemorrhaging at the operating level. Year-on-year, sales grew 9.21% from ₹0.76 crores in Q4 FY25, but this marginal uptick offers little comfort given the scale of operational dysfunction.
Operating profit before depreciation, interest, tax, and other income (PBDIT excluding OI) plummeted to a catastrophic loss of ₹2.02 crores in Q4 FY26—the worst quarterly performance in at least seven quarters. This translated into an operating margin of -243.37%, a dramatic deterioration from -50.00% in Q3 FY26 and -34.21% in Q4 FY25. The company's cost structure appears fundamentally misaligned with its revenue-generating capacity, with employee costs alone consuming ₹0.31 crores against sales of just ₹0.83 crores.
Other income provided a temporary cushion of ₹1.27 crores in Q4 FY26—a significant spike from ₹0.06 crores in the previous quarter—likely from one-off asset realisations or investment income. However, this non-operating income merely masked the underlying operational carnage. Even after accounting for this windfall, the company recorded a pre-tax loss of ₹1.10 crores, with net losses reaching ₹1.01 crores after a marginal tax credit of ₹0.09 crores.
For the full year FY25, the company reported net sales of ₹2.00 crores—unchanged from FY24, FY23, and FY22—demonstrating complete revenue stagnation over a four-year period. Annual net losses for FY25 stood at ₹1.00 crore, a reversal from breakeven in FY24 and profit of ₹1.00 crore in FY23. The pattern suggests episodic profitability driven by non-operating income rather than sustainable business operations.
Critical Operating Dysfunction
Red Flag: Operating margins excluding other income have deteriorated to -243.37% in Q4 FY26, the worst quarterly performance on record. The company's core business is consuming capital at an alarming rate, with no visible path to operational break-even. Employee costs and other operating expenses far exceed revenue-generating capacity, indicating a fundamentally broken business model that requires immediate restructuring or exit.
Capital Efficiency: Negative Returns and Eroding Shareholder Value
Kemp & Co.'s capital efficiency metrics tell a damning story of value destruction. The company's latest return on equity (ROE) stands at -0.93%, reflecting its inability to generate positive returns for shareholders. The average ROE over recent years registers at a meagre 0.16%—essentially zero returns on shareholder capital deployed. This compares unfavourably even against risk-free instruments, making the equity investment proposition deeply unattractive from a fundamental standpoint.
Return on capital employed (ROCE) presents an equally bleak picture at -0.82% for the latest period, with a multi-year average of -0.67%. The negative ROCE indicates that the company is destroying value on the total capital base, failing to generate sufficient operating profits to justify the capital invested in the business. With sales to capital employed averaging just 0.02x, the company's asset base is generating virtually no productive output.
The balance sheet reveals shareholder funds of ₹129.54 crores as of March 2025, down from ₹211.80 crores in March 2024—a staggering erosion of ₹82.26 crores or 38.84% in a single year. Reserves and surplus contracted from ₹210.72 crores to ₹128.46 crores, reflecting accumulated losses and potential dividend distributions that have hollowed out the capital base. The company maintains investments of ₹126.70 crores, down from ₹223.47 crores, suggesting asset liquidations to fund ongoing losses.
Positively, the company carries zero debt, eliminating financial leverage risk. Current liabilities stand at a modest ₹0.79 crores, comprising primarily trade payables of ₹0.38 crores. However, the absence of debt is a function of the company's inability to service borrowings rather than prudent financial management. With persistently negative cash flows from operations—₹1.00 crore outflow in FY25 and ₹2.00 crores in FY24—the company would struggle to meet any debt obligations.
Balance Sheet Erosion: A Capital Base Under Siege
Shareholder funds have collapsed from ₹211.80 crores in March 2024 to ₹129.54 crores in March 2025—a 38.84% decline driven by accumulated losses and potential distributions. With investments shrinking from ₹223.47 crores to ₹126.70 crores, the company appears to be liquidating assets to fund operations. The book value per share stands at ₹1,199.21, yet the stock trades at ₹1,009.85, a 15.79% discount, signalling market scepticism about the realisable value of assets and future earnings potential.
Industry Context: Struggling Within a Niche Segment
Kemp & Co. operates within the diversified commercial services sector, a broad classification that encompasses companies with varied business models and revenue streams. The company's historical roots in pharmaceutical retail and subsequent diversifications have left it without a clear competitive positioning or sustainable revenue model. Unlike peers with defined service offerings or product portfolios, Kemp & Co.'s business profile remains nebulous, contributing to its operational challenges.
The diversified commercial services industry in India has witnessed varied performance across different sub-segments. Companies with focused business models, strong client relationships, and scalable operations have generally outperformed, whilst those lacking strategic clarity or operational efficiency have struggled. Kemp & Co. falls decisively into the latter category, with stagnant revenues, mounting losses, and no discernible competitive advantages.
Over the past year, the stock has underperformed its sector benchmark by 15.57%, with Kemp & Co. delivering a -25.85% return compared to the Diversified Commercial Services sector return of -10.28%. This underperformance reflects investor recognition of the company's deteriorating fundamentals and lack of credible turnaround prospects. The broader market has also declined 7.25% over the same period, but Kemp & Co.'s negative alpha of -18.60% highlights company-specific distress beyond general market weakness.
| Company | P/E (TTM) | P/BV | ROE (%) | Debt to Equity | Div Yield (%) |
|---|---|---|---|---|---|
| Kemp & Co. | NA (Loss Making) | 0.68 | 0.16 | 0.00 | NA |
| Eyantra Ventures | NA (Loss Making) | 5.30 | 7.71 | 0.55 | NA |
| Ruchi Infrastructure | 14.03 | 0.71 | 6.36 | 0.30 | NA |
| NSB BPO | 16.04 | 0.98 | 0.00 | 0.00 | NA |
| Coral India Finance | 9.21 | 0.62 | 10.24 | 0.00 | 1.21 |
| TCI Industries | 246.62 | 8.43 | 0.00 | 0.10 | NA |
Relative to its peer group, Kemp & Co. exhibits the weakest return on equity at 0.16%, compared to peer averages around 5-6% for profitable companies. The stock trades at a price-to-book value of 0.68x—the second-lowest in the peer set—reflecting the market's deep discount on the company's asset base. Whilst the zero debt position appears favourable, it offers little competitive advantage when the core business generates persistently negative returns.
Valuation Analysis: Discount Reflects Distress, Not Opportunity
Kemp & Co.'s valuation metrics underscore the market's profound pessimism about the company's prospects. With the stock loss-making, traditional price-to-earnings ratios are not applicable. The price-to-book value of 0.68x represents a 32% discount to book value, typically a sign of either undervaluation or, more commonly in distressed situations, recognition that book assets will not be realised at stated values.
The company's enterprise value to sales ratio stands at 39.28x—an extraordinarily high multiple given the minuscule revenue base and negative profitability. This reflects the company's substantial investment portfolio and cash-like assets, which dominate the enterprise value calculation. However, EV/EBITDA of -84.96x and EV/EBIT of -79.65x are meaningless in the context of negative operating profits, serving only to highlight the operational dysfunction.
The valuation grade has been classified as "RISKY" since April 2023, with multiple downgrades over the years reflecting deteriorating financial performance. The stock's 52-week range of ₹868.30 to ₹1,559.95 illustrates extreme volatility, with the current price of ₹1,009.85 sitting 35.26% below the 52-week high and 16.30% above the 52-week low. This volatility reflects uncertainty about asset realisations, potential restructuring, or exit scenarios rather than fundamental business prospects.
The last dividend of ₹12 per share was paid in September 2023, with no subsequent distributions despite the company's mounting losses. The dividend payout ratio stands at 0.0%, reflecting the absence of distributable profits. For investors, the 32% discount to book value is not an entry opportunity but rather a reflection of legitimate concerns about asset quality, earnings power, and the company's ability to preserve—let alone grow—shareholder capital.
Shareholding: Promoter Dominance, Institutional Absence
Promoter holding in Kemp & Co. stands at 74.88% as of March 2026, representing a marginal increase of 0.17 percentage points from 74.71% in December 2025. The promoter group, led by Piramal Vibhuti Investments Limited (68.12%), D G P Securities Limited (6.55%), and Alcon Finance & Investments Limited (0.03%), maintains dominant control over the company. Importantly, there is zero promoter pledging, eliminating concerns about forced selling or margin calls.
Institutional participation is virtually non-existent, with foreign institutional investors (FII) and mutual funds holding 0.00% stakes. Other domestic institutional investors (DII) maintain a token 0.09% holding, unchanged over the past five quarters. Insurance companies also hold no position. The 25.03% non-institutional shareholding comprises primarily retail investors and non-institutional entities, down marginally from 25.21% in the previous quarter.
| Quarter | Promoter (%) | FII (%) | Mutual Funds (%) | Insurance (%) | Other DII (%) | Non-Inst (%) |
|---|---|---|---|---|---|---|
| Mar'26 | 74.88 | 0.00 | 0.00 | 0.00 | 0.09 | 25.03 |
| Dec'25 | 74.71 | 0.00 | 0.00 | 0.00 | 0.09 | 25.21 |
| Sep'25 | 74.71 | 0.00 | 0.00 | 0.00 | 0.09 | 25.21 |
| Jun'25 | 74.71 | 0.00 | 0.00 | 0.00 | 0.09 | 25.21 |
| Mar'25 | 74.71 | 0.00 | 0.00 | 0.00 | 0.09 | 25.21 |
The complete absence of institutional investors signals a lack of confidence in the company's business model, governance, or turnaround prospects. Sophisticated investors have clearly avoided the stock, leaving it primarily in promoter and retail hands. The marginal uptick in promoter holding suggests either open market purchases or other corporate actions, but offers little comfort given the deteriorating operational performance. The shareholding pattern underscores the company's status as a micro-cap with limited institutional appeal and questionable liquidity.
Stock Performance: Severe Underperformance Across All Timeframes
Kemp & Co.'s stock performance has been dismal across most relevant timeframes, reflecting the market's recognition of the company's fundamental challenges. Over the past one year, the stock has delivered a -25.85% return, significantly underperforming the Sensex's -7.25% decline and generating a negative alpha of -18.60 percentage points. Year-to-date, the stock is down 10.00%, marginally outperforming the Sensex's -10.56% decline by a mere 0.56 percentage points.
Short-term performance has been particularly brutal. Over the past week, the stock plunged 9.74% whilst the Sensex gained 1.36%, resulting in a negative alpha of -11.10 percentage points. The one-month return stands at -4.49% against the Sensex's -0.58%, whilst the six-month return of -21.26% compares unfavourably to the Sensex's -10.97% decline. The three-month period provided a rare bright spot with a 6.86% gain against the Sensex's -7.33% fall, generating a positive alpha of 14.19 percentage points—likely driven by short-term technical factors or speculative interest rather than fundamental improvements.
| Period | Stock Return (%) | Sensex Return (%) | Alpha (%) |
|---|---|---|---|
| 1 Day | -5.00 | -0.35 | -4.65 |
| 1 Week | -9.74 | +1.36 | -11.10 |
| 1 Month | -4.49 | -0.58 | -3.91 |
| 3 Month | +6.86 | -7.33 | +14.19 |
| 6 Month | -21.26 | -10.97 | -10.29 |
| YTD | -10.00 | -10.56 | +0.56 |
| 1 Year | -25.85 | -7.25 | -18.60 |
| 2 Years | +9.41 | +1.08 | +8.33 |
| 3 Years | +41.04 | +21.95 | +19.09 |
| 5 Years | +135.15 | +49.40 | +85.75 |
Longer-term returns present a more complex picture. The two-year return of 9.41% outperforms the Sensex's 1.08% by 8.33 percentage points, whilst the three-year return of 41.04% surpasses the Sensex's 21.95% by 19.09 percentage points. The five-year return of 135.15% significantly outpaces the Sensex's 49.40%, generating an impressive alpha of 85.75 percentage points. However, these longer-term gains largely reflect the stock's recovery from extremely depressed levels during 2020-2021 rather than sustained fundamental improvement.
Technical indicators paint a bearish picture. The stock currently trades below all key moving averages: 5-day MA (₹1,107.67), 20-day MA (₹1,157.96), 50-day MA (₹1,067.32), and 100-day MA (₹1,177.21). The overall technical trend is classified as "MILDLY BEARISH" as of April 23, 2026, with MACD showing mildly bullish signals on weekly charts but bearish on monthly charts. Bollinger Bands indicate bearish momentum on both weekly and monthly timeframes. The stock's beta of 1.50 classifies it as a high-beta security, exhibiting 50% greater volatility than the broader market—a characteristic that amplifies both gains and losses.
Investment Thesis: Distressed Asset with No Visible Catalysts
Kemp & Co.'s investment thesis—or lack thereof—centres on its status as a distressed micro-cap with persistently negative operating performance, eroding shareholder capital, and no credible turnaround strategy. The company's quality grade stands at "BELOW AVERAGE", reflecting weak long-term financial performance characterised by negative EBIT growth, minimal return on equity, and operational losses. The valuation grade of "RISKY" appropriately captures the elevated risk profile, whilst the financial trend is classified as "NEGATIVE" following the catastrophic Q4 FY26 results.
The proprietary Mojo score of 9 out of 100 places the stock firmly in "STRONG SELL" territory, with the advisory recommending investors "strongly consider selling" or executing an exit. This score reflects the confluence of negative factors: bearish technical trends, deteriorating financial performance, weak fundamental strength, and significant underperformance relative to both the market and sector benchmarks.
For prospective investors, the company offers no compelling entry point. The 32% discount to book value reflects legitimate concerns about asset realisability and ongoing value destruction rather than a margin of safety. The absence of institutional interest, combined with persistently negative cash flows from operations and mounting losses, suggests the company is in a slow liquidation mode—whether managed or unmanaged. The promoter group's continued dominance provides governance stability but offers no guarantee of operational turnaround or capital preservation.
Key Strengths & Risk Factors
Key Strengths
- Zero Debt Position: Complete absence of financial leverage eliminates bankruptcy risk and interest burden, providing financial flexibility
- No Promoter Pledging: Zero pledged shares indicate promoter confidence and eliminate forced selling risk from margin calls
- Stable Promoter Holding: Promoter stake of 74.88% provides governance stability and aligned interests, with marginal increase in recent quarter
- Substantial Investment Portfolio: Investments of ₹126.70 crores provide potential liquidity cushion, though declining from previous levels
- Long Operating History: Incorporated in 1982 with established corporate structure and regulatory compliance track record
Key Concerns
- Catastrophic Operating Losses: Operating margin of -243.37% in Q4 FY26 represents worst quarterly performance, indicating fundamentally broken business model
- Persistent Revenue Stagnation: Annual sales stuck at ₹2-3 crores for four consecutive years with no growth trajectory or scalability
- Negative Return on Equity: ROE of -0.93% reflects systematic shareholder value destruction and capital inefficiency
- Severe Balance Sheet Erosion: Shareholder funds collapsed 38.84% from ₹211.80 crores to ₹129.54 crores in one year due to accumulated losses
- Complete Institutional Exodus: Zero FII and mutual fund holdings signal lack of confidence; only 0.09% DII participation
- Negative Operating Cash Flows: Persistent cash outflows from operations (₹1-2 crores annually) indicate unsustainable business model
- Unclear Business Model: Multiple failed diversifications and opaque current operations provide no visibility on future revenue streams
Outlook: What to Watch for Deterioration or Stabilisation
Positive Catalysts (Low Probability)
- Strategic Restructuring: Announcement of business model overhaul, asset monetisation, or merger with viable entity
- Revenue Breakthrough: Quarterly sales exceeding ₹2 crores sustainably with positive operating margins
- Cost Rationalisation: Employee costs and operating expenses reduced to align with revenue-generating capacity
- Asset Realisation: Monetisation of investment portfolio at or above book value to return capital to shareholders
- Institutional Interest: Entry of credible institutional investors signalling confidence in turnaround prospects
Red Flags (High Probability)
- Further Margin Deterioration: Operating margins falling below -250% indicating accelerating cash burn
- Continued Revenue Decline: Quarterly sales falling below ₹0.60 crores or annual sales below ₹2 crores
- Shareholder Fund Depletion: Balance sheet erosion continuing below ₹100 crores, threatening viability
- Promoter Stake Reduction: Any decline in promoter holding below 70% signalling loss of confidence or forced asset sales
- Regulatory Actions: SEBI or exchange notices regarding governance, disclosure, or compliance failures
- Going Concern Doubts: Auditor qualifications questioning the company's ability to continue as a going concern
The Verdict: Distressed Micro-Cap with No Credible Turnaround Path
Score: 9/100
For Fresh Investors: Avoid entirely. The company exhibits all characteristics of a distressed asset—catastrophic operating margins of -243%, negative ROE, persistent losses, revenue stagnation, and complete absence of institutional support. The 32% discount to book value is not a buying opportunity but a reflection of legitimate concerns about asset quality and ongoing value destruction. There is no credible investment thesis supporting capital deployment at current levels.
For Existing Holders: Consider immediate exit to preserve remaining capital. The Q4 FY26 results represent a significant deterioration from already weak performance, with operating losses accelerating and shareholder funds eroding at an alarming 38.84% annually. The company demonstrates no path to operational break-even, sustainable profitability, or capital preservation. Whilst the zero-debt position eliminates bankruptcy risk, it does not prevent continued value destruction through operating losses. The stock's high beta of 1.50 amplifies downside risk in weak markets.
Fair Value Estimate: Not applicable. Traditional valuation metrics are meaningless for a persistently loss-making entity with no visible earnings power. The stock's value is contingent on potential asset liquidation or strategic restructuring, neither of which appears imminent. Current price of ₹1,009.85 likely overvalues the business on a going-concern basis.
Rationale: The STRONG SELL rating reflects the confluence of catastrophic operating performance, systematic capital destruction, absence of credible turnaround catalysts, and complete lack of institutional confidence. With operating margins at -243%, negative returns on equity and capital, and annual shareholder fund erosion of nearly 40%, the company is destroying value at an accelerating rate. The micro-cap status, limited liquidity, and opaque business model compound the investment risk. Investors are strongly advised to exit positions and redeploy capital into fundamentally sound businesses with sustainable competitive advantages and positive return profiles.
Note— ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. The views expressed are based on data available as of May 26, 2026, and are subject to change.
